Flagship explainer
What drives TherapeuticsMD, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$569000 | FY2025 |
| |
| Income before tax | −$653000 | FY2025 |
|
| Operating income | −$4.4M | FY2025 |
|
| $3M | FY2025 |
| |
| Ending assets | $37.7M | FY2025 |
|
| Beginning assets | $38.8M | FY2024 |
|
| $26.9M | FY2025 |
| |
| $27.4M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001013762-25-003442
- SEC filingFiling detailsAccession 0001213900-26-037918